Matija Crnogorac

Zagreb, Croatia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

Editorial: ANCA-associated vasculitis treatment: outcomes and complications.

Editorial: ANCA-associated vasculitis treatment: outcomes and complications.

Journal: Frontiers in immunology

Published: October 07, 2025

Kidney Outcomes in ANCA-Glomerulonephritis According to Induction Immunosuppression and Histopathology.

Kidney Outcomes in ANCA-Glomerulonephritis According to Induction Immunosuppression and Histopathology.

Journal: Kidney international reports

Published: August 12, 2025

Aetiology of acute/subacute nephritic syndrome: results from kidney biopsy registries in Japan and Europe.

Aetiology of acute/subacute nephritic syndrome: results from kidney biopsy registries in Japan and Europe.

Journal: BMC nephrology

Published: June 08, 2025

Response to the Letter to the Editor Entitled "Focusing on Older Adults With Antineutrophil Cytoplasmic Autoantibody Negative Pauci-Immune Glomerulonephritis".

Response to the Letter to the Editor Entitled "Focusing on Older Adults With Antineutrophil Cytoplasmic Autoantibody Negative Pauci-Immune Glomerulonephritis".

Journal: Kidney international reports

Published: March 20, 2025

Clinical Presentation and Outcomes of Antineutrophil Cytoplasmic Autoantibody-Negative Pauci-Immune Glomerulonephritis.

Clinical Presentation and Outcomes of Antineutrophil Cytoplasmic Autoantibody-Negative Pauci-Immune Glomerulonephritis.

Journal: Kidney international reports

Published: January 24, 2025

Long-Term Outcomes of Rituximab-Treated Adult Patients with Podocytopathies.

Long-Term Outcomes of Rituximab-Treated Adult Patients with Podocytopathies.

Journal: Journal of the American Society of Nephrology : JASN

Published: June 16, 2024

Traditional and Disease Specific Risk Factors for Cardiovascular Events in ANCA-Associated Vasculitis: A Multinational Retrospective Study.

Traditional and Disease Specific Risk Factors for Cardiovascular Events in ANCA-Associated Vasculitis: A Multinational Retrospective Study.

Journal: The Journal of rheumatology

Published: August 01, 2023

Traditional and Disease-Specific Risk Factors for Cardiovascular Events in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: A Multinational Retrospective Study.

Traditional and Disease-Specific Risk Factors for Cardiovascular Events in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: A Multinational Retrospective Study.

Journal: The Journal of rheumatology

Published: November 25, 2022

Association of venous thromboembolic events with skin, pulmonary and kidney involvement in ANCA-associated vasculitis: a multinational study.

Association of venous thromboembolic events with skin, pulmonary and kidney involvement in ANCA-associated vasculitis: a multinational study.

Journal: Rheumatology (Oxford, England)

Published: October 21, 2020

Rituximab in Membranous Nephropathy.

Rituximab in Membranous Nephropathy.

Journal: Kidney international reports

Published: September 23, 2020

Rituximab in adult minimal change disease and focal segmental glomerulosclerosis - What is known and what is still unknown?

Rituximab in adult minimal change disease and focal segmental glomerulosclerosis - What is known and what is still unknown?

Journal: Autoimmunity reviews

Published: May 01, 2020

Proteinase-3 and myeloperoxidase serotype in relation to demographic factors and geographic distribution in anti-neutrophil cytoplasmic antibody-associated glomerulonephritis.

Proteinase-3 and myeloperoxidase serotype in relation to demographic factors and geographic distribution in anti-neutrophil cytoplasmic antibody-associated glomerulonephritis.

Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association

Published: December 13, 2017

Showing 1-12 of 17

Last Updated: 09/26/2026